From clinical evidence to competitive strategy, OncRef brings drugs, trials, approvals, guidelines, publications and congress intelligence into one connected platform.


Pick the cancers you treat and get curated trials, approvals and guideline updates at the point of care. Free for practicing clinicians.
Explore Clinical
Monthly reports by cancer type, congress summaries and audio highlights — curated by experts.
Explore Signal
Company-specific competitive intelligence, portfolio monitoring and evidence-backed implications for Medical Affairs, Clinical Development and Commercial.
Explore FalconA live tour through OncRef — congress intelligence, your NewsFeed, the full oncology pipeline, monthly reports, trials, and more.
560+ cancer subtypes. 4,600+ new oncology trials a year. Updates across trials, drugs, approvals, guidelines and congresses every day — from sources that don't talk to each other. OncRef is the layer that connects them.


Every drug, company, trial and guideline is resolved to a single normalized entity — deterministic, source-linked and updated daily. Less searching. More deciding.

“I love this because I can go in and pick my cancer type. Not every app is oncology specific.”
Monika Buczek, PhDDirector, Taconic Biosciences Strategy, Operations, Product, and Innovation“This is really cool. I've never seen anything like this.”
Patrick Tucker, PhDVP of Medical Communications“OncRef will save me 3 to 5 hours each month and more for doctors!”
Jacqueline Lavigne, NPOncology NP



OncRef is a cancer-specific, point-of-care resource that streamlines oncology research, provides actionable insights, and helps oncology professionals make data-driven decisions — the field of cancer in one place, with medical expert curation.
Same oncology graph — built into how you work.
Curated trials, approvals and guideline updates for the cancers you treat — at the point of care.
Request accessSee the intelligence layer applied to your indications and competitors — 30 minutes, no slides.
Book an industry demo